J. Stathopoulos

555 total citations
18 papers, 454 citations indexed

About

J. Stathopoulos is a scholar working on Oncology, Molecular Biology and Hepatology. According to data from OpenAlex, J. Stathopoulos has authored 18 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Hepatology. Recurrent topics in J. Stathopoulos's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Research Studies (7 papers) and Cancer therapeutics and mechanisms (6 papers). J. Stathopoulos is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Lung Cancer Research Studies (7 papers) and Cancer therapeutics and mechanisms (6 papers). J. Stathopoulos collaborates with scholars based in Greece and Belgium. J. Stathopoulos's co-authors include George P. Stathopoulos, J. Dimitroulis, D. Antoniou, S. Rigatos, Athanasios Armakolas, Dimitrios T. Trafalis, Spyros Batzios, G. Stathopoulos, Niki Georgatou and M. Toubis and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

J. Stathopoulos

18 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Stathopoulos Greece	11	273	152	126	98	89	18	454
Susanne Arns Germany	11	140 0.5×	137 0.9×	106 0.8×	94 1.0×	175 2.0×	13	532
Man Shu China	11	145 0.5×	101 0.7×	99 0.8×	93 0.9×	121 1.4×	25	418
Teresa Puértolas Spain	9	291 1.1×	147 1.0×	62 0.5×	127 1.3×	58 0.7×	29	499
G. Retalis Greece	8	119 0.4×	68 0.4×	115 0.9×	221 2.3×	108 1.2×	14	547
Amane Takahashi Japan	12	180 0.7×	217 1.4×	116 0.9×	96 1.0×	75 0.8×	36	585
Danian Tong China	12	129 0.5×	153 1.0×	43 0.3×	53 0.5×	38 0.4×	17	401
Austin J. Combest United States	9	290 1.1×	213 1.4×	76 0.6×	198 2.0×	57 0.6×	19	565
Veronika Ecker Germany	8	149 0.5×	180 1.2×	64 0.5×	62 0.6×	46 0.5×	12	404

Countries citing papers authored by J. Stathopoulos

Since Specialization

Citations

This map shows the geographic impact of J. Stathopoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Stathopoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Stathopoulos more than expected).

Fields of papers citing papers by J. Stathopoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Stathopoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Stathopoulos. The network helps show where J. Stathopoulos may publish in the future.

Co-authorship network of co-authors of J. Stathopoulos

This figure shows the co-authorship network connecting the top 25 collaborators of J. Stathopoulos. A scholar is included among the top collaborators of J. Stathopoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Stathopoulos. J. Stathopoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Stathopoulos, George P., J. Stathopoulos, & J. Dimitroulis. (2012). Two consecutive days of treatment with liposomal cisplatin in non-small cell lung cancer. Oncology Letters. 4(5). 1013–1016. 7 indexed citations

Stathopoulos, George P., Dimitrios T. Trafalis, J. Dimitroulis, et al.. (2012). Combination of three cytotoxic agents in small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 71(2). 413–418. 3 indexed citations

Stathopoulos, George P., et al.. (2011). Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 68(4). 945–950. 83 indexed citations

Stathopoulos, J., Athanasios Armakolas, G. Stathopoulos, & Ilias P. Gomatos. (2010). Plasma VEGF levels in breast cancer patients with and without metastases. Oncology Letters. 1(4). 739–741. 9 indexed citations

Stathopoulos, George P., et al.. (2010). Treatment of Colorectal Cancer with and without Bevacizumab: A Phase III Study. Oncology. 78(5-6). 376–381. 96 indexed citations

Stathopoulos, George P., S. Rigatos, & J. Stathopoulos. (2010). Liposomal cisplatin dose escalation for determining the maximum tolerated dose and dose-limiting toxicity: a phase I study.. PubMed. 30(4). 1317–21. 11 indexed citations

Stathopoulos, George P., D. Antoniou, J. Dimitroulis, et al.. (2010). Liposomal cisplatin combined with paclitaxel versus cisplatin and paclitaxel in non-small-cell lung cancer: a randomized phase III multicenter trial. Annals of Oncology. 21(11). 2227–2232. 90 indexed citations

Antoniou, D., et al.. (2010). Comparison of response rate of advanced non-small lung cancer patients to liposomal cisplatin versus cisplatin both combined with paclitaxel: A phase III trial.. Journal of Clinical Oncology. 28(15_suppl). 7579–7579. 1 indexed citations

Stathopoulos, George P., et al.. (2008). Surgical management in lung metastases from colorectal cancer.. PubMed. 27(6C). 4387–90. 11 indexed citations

10.

Stathopoulos, G., et al.. (2007). Liposomal cisplatin and paclitaxel versus cisplatin and paclitaxel in advanced NSCLC. Journal of Clinical Oncology. 25(18_suppl). 7684–7684. 1 indexed citations

11.

Stathopoulos, George P., et al.. (2007). Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects.. PubMed. 27(3B). 1653–6. 25 indexed citations

12.

Stathopoulos, George P., N. Malamos, Gerasimos Aravantinos, et al.. (2006). Weekly administration of topotecan–paclitaxel as second-line treatment in ovarian cancer. Cancer Chemotherapy and Pharmacology. 60(1). 123–128. 10 indexed citations

13.

Stathopoulos, George P., et al.. (2006). Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase II trial. Cancer Chemotherapy and Pharmacology. 58(4). 555–560. 5 indexed citations

14.

Stathopoulos, George P., et al.. (2005). Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I–II trial. British Journal of Cancer. 93(10). 1106–1111. 20 indexed citations

15.

Stathopoulos, George P., J. Stathopoulos, D. Skarlos, et al.. (2005). Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study. Cancer Chemotherapy and Pharmacology. 57(6). 796–800. 12 indexed citations

16.

Stathopoulos, G., D. Tsavdaridis, N. Malamos, et al.. (2005). Irinotecan combined with docetaxel in pre-treated metastatic breast cancer patients: a phase II study. Cancer Chemotherapy and Pharmacology. 56(5). 487–491. 18 indexed citations

17.

Christodoulou, Christos, et al.. (2004). Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study. Cancer Chemotherapy and Pharmacology. 54(3). 259–64. 13 indexed citations

18.

Stathopoulos, G., S. Rigatos, Meletios Α. Dimopoulos, et al.. (2003). Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. Annals of Oncology. 14(3). 388–394. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susanne Arns Breakdown of academic impact, for papers by Man Shu Breakdown of academic impact, for papers by Teresa Puértolas Breakdown of academic impact, for papers by G. Retalis Breakdown of academic impact, for papers by Amane Takahashi Breakdown of academic impact, for papers by Danian Tong Breakdown of academic impact, for papers by Austin J. Combest Breakdown of academic impact, for papers by Veronika Ecker